Institute for Health Metrics and Evaluation (IHME)

Institute for Health Metrics and Evaluation (IHME) The Institute for Health Metrics and Evaluation (IHME) is an independent research center at UW Vision: All people living long lives in full health.

An independent population health research organization based at the University of Washington School of Medicine, the Institute for Health Metrics and Evaluation (IHME) works with collaborators around the world to develop timely, relevant, and scientifically valid evidence that illuminates the state of health everywhere. In making our research available and approachable, we aim to inform health policy and practice in pursuit of our vision: all people living long lives in full health. Mission: IHME delivers to the world timely, relevant, and scientifically valid evidence to improve health policy and practice. Research: IHME’s research is organized around answering three critical questions that are essential to understanding the current state of population health and the strategies necessary to improve it. What are the world's major health problems? How well is society addressing these problems? How do we best dedicate resources to maximize health improvement? At the same time, we are expanding the field of health metrics by training the next generation of global health leaders in a science that is both accountable and transparent. We are also commited to data transparency and sharing and have launched the Global Health Data Exchange (GHDx) where methods and results will be freely accessible to all. Thanks to long-term funding from the Bill & Melinda Gates Foundation and support from the state of Washington, we have been able to set an ambitious agenda for the Institute.

Mark your calendar for GBD Learning Week from October 27–31! Explore cutting-edge topics in GBD research, sharpen your s...
10/21/2025

Mark your calendar for GBD Learning Week from October 27–31! Explore cutting-edge topics in GBD research, sharpen your skills with hands-on demonstrations of GBD 2023 methods and tools, and engage directly with the global community of health metrics scientists.

Learn more and register: http://ms.spr.ly/6186sCDFG

10/17/2025

Dr. Adekemi Adeniyan, Executive Director of the Dentalcare Foundation, rural dentist, and advocate for oral health advancement in Nigeria, has been named IHM...

10/16/2025

We are happy to celebrate this year’s Roux Prize winner, Dr. Adekemi Adeniyan (Kikelomo Neriah Adeniyan), health care advocate, rural dentist, and innovator working to address inequities in Nigeria, where less than 20% of the population has access to oral health care.

Dr. Adeniyan has made strides as Executive Director of the Dentalcare Foundation and the founder of Smile Superheroes, an organization that provides creative and engaging oral health care education to children and their families.

Learn more about Dr. Adeniyan’s work:
• Roux Prize video: http://ms.spr.ly/6188sfddY
• Podcast interview: http://ms.spr.ly/6189sfddl
• In-depth infographic: http://ms.spr.ly/6180sfddm

Nominations for the Roux Prize 2026 will open in November: http://ms.spr.ly/6181sfddW

We have new video resources available for the release of the Global Burden of Disease (GBD) 2023 study!• GBD Learning vi...
10/15/2025

We have new video resources available for the release of the Global Burden of Disease (GBD) 2023 study!

• GBD Learning videos: drill down into updated tools, methods, and data for each of the GBD 2023 capstones published in The Lancet
• Videos with IHME Director Dr. Chris Murray as he discusses findings and shares figures from GBD 2023
• Recording of the World Health Summit GBD 2023 launch event on Oct. 12

Check out all the videos ↓

The GBD 2023 study was officially released on October 12, 2025 at the World Health Summit in Berlin! Learn more about the new data, methods, and tools.

Almost half of the global mortality and morbidity in 2023 was attributable to 88 modifiable risk factors.  The 10 risk f...
10/12/2025

Almost half of the global mortality and morbidity in 2023 was attributable to 88 modifiable risk factors.

The 10 risk factors with the highest proportion of health loss were high systolic blood pressure, particulate matter pollution, smoking, high fasting plasma glucose, low birthweight and short gestation, high body mass index (adult), kidney dysfunction, high low-density lipoprotein cholesterol, child growth failure, and lead exposure.

Between 2010 and 2023, disability-adjusted life year rates for high body mass index rose by almost 11%, drug use by nearly 9%, and high blood sugar by 6%.

• Read the new GBD 2023 capstone published in The Lancet that analyzes the global burden of diseases, injuries, and risk factors: http://ms.spr.ly/6182s2bte

• Explore the related infographic: http://ms.spr.ly/6185s2bt9

Causes of death are shifting from infectious to non-communicable diseases, creating new global health challenges, partic...
10/12/2025

Causes of death are shifting from infectious to non-communicable diseases, creating new global health challenges, particularly for low-income countries.

COVID-19, the leading cause of death in 2021, dropped to 20th place in 2023. Ischemic heart disease and stroke ranked first and second in 2023, followed by chronic obstructive pulmonary disease, lower respiratory infections, and neonatal disorders.

Read the GBD 2023 capstone published in The Lancet that examines global causes of death in 204 countries and territories from 1950 to 2023: http://ms.spr.ly/6180s2bYG

View and share the related infographic: http://ms.spr.ly/6182s2bYy

Highlights from the GBD 2023 demographics capstone, an analysis of estimates for all-cause mortality and life expectancy...
10/12/2025

Highlights from the GBD 2023 demographics capstone, an analysis of estimates for all-cause mortality and life expectancy (LE):

• LE and mortality have largely returned to pre-COVID levels.
• Mortality among children, adolescents, and young adults has declined in most regions except Eastern Europe and high-income North America.
• New data and methods uncovered higher mortality among women in sub-Saharan Africa than previously reported.

Read the research, published in The Lancet: http://ms.spr.ly/6187s2be1
Check out the accompanying infographic: http://ms.spr.ly/6180s2bey

We are excited to announce the official release of the Global Burden of Disease 2023 study! Three GBD 2023 capstones hav...
10/12/2025

We are excited to announce the official release of the Global Burden of Disease 2023 study!

Three GBD 2023 capstones have just been published in The Lancet:
• Global demographic analysis: http://ms.spr.ly/6188s2bOa
• Global causes of death: http://ms.spr.ly/6183s2bOF
• Global burden of diseases, injuries, and risk factors: http://ms.spr.ly/6185s2bON

Tune in now to the launch event at the World Health Summit to hear global health leaders and IHME experts discuss the GBD 2023 study: http://ms.spr.ly/6188s2bOA

GBD 2023 data visualization tools, videos, infographics, and resources are now available: http://ms.spr.ly/6189s2bO7

Coming soon! This Sunday, October 12, the Global Burden of Disease (GBD) 2023 study will be officially released at the W...
10/10/2025

Coming soon! This Sunday, October 12, the Global Burden of Disease (GBD) 2023 study will be officially released at the World Health Summit in Berlin.

Join online from 07:00–08:30 PT / 16:00–17:30 CEST / 14:00–15:30 UTC to learn about GBD 2023 from a panel of IHME experts and global health leaders from around the world.

• Learn more about the upcoming session: http://ms.spr.ly/6182sFo6Y
• Join the session online: http://ms.spr.ly/6183sFo6l

The Lancet, World Health Organization (WHO), Aga Khan University, University of British Columbia, UCL, Queensland Centre for Mental Health Research

10/09/2025
There are stark differences in cancer burden across the globe. Although globally, age-standardized cancer death rates de...
10/09/2025

There are stark differences in cancer burden across the globe. Although globally, age-standardized cancer death rates decreased by 24% from 1990 to 2023, this reduction was driven by high- and upper-middle-income countries.

Age-standardized cancer incidence rates increased in low-income (+24%) and lower-middle-income countries (+29%) during this time. Learn more about the global cancer burden and forecasts to 2050 from a major new analysis from the Global Burden of Disease Study Cancer Collaborators, published in The Lancet: http://ms.spr.ly/6184sFGiG

10/08/2025

What is driving changes in cardiovascular diseases (CVDs) in each country? Dr. Greg Roth, lead author of a comprehensive study on the global burden of CVD and associated risk factors, presents new findings in a Q&A video.

Dr. Roth is a Professor in the Division of Cardiology and Adjunct Professor of Health Metrics Sciences at IHME at the University of Washington School of Medicine. He is the Director for the Program in Cardiovascular Health Metrics at IHME.

Read the study: http://ms.spr.ly/6181s0X1V
Watch the full Q&A video: http://ms.spr.ly/6183s0X1X

Address

3980 15th Avenue NE
Seattle, WA
98195

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when Institute for Health Metrics and Evaluation (IHME) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram